We collect analytics data in order to understand site usage. This data is collected anonymously and is not associated to you personally. Decide what you want to share with us below.
Oxfam has hailed the Indian Supreme Court’s ruling against a patent protection petition filed by multinational pharmaceutical company Novartis as a huge victory for public health.
Mohga Kamal-Yanni, Oxfam senior policy adviser, said: “Oxfam is delighted that GAVI has raised more than $4bn to vaccinate children against killer diseases.